Conversely, Oshim et al. identified FSTL1 as a cardiac protective factor, showing that administration of recombinant FSTL1 to mice reduced myocardial infarct size and cardiomyocyte apoptosis following ischemia/reperfusion injury [19]. The gene discussed is FSTL1; the disease is myocardial infarction.